Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 661 AL 675

The relationship between glucocerebrosidase mutations and Parkinson disease

Migdalska-Richards A, Schapira AH.

J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10.

Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance

Blanz J, Saftig P.

J Neurochem. 2016 Oct;139 Suppl 1:198-215. doi: 10.1111/jnc.13517. Epub 2016 Feb 10.

Teaching neurons to respond to placebos

Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, Zibetti M, Lanotte M, Lopiano L.

J Physiol. 2016 Oct 1;594(19):5647-60. doi: 10.1113/JP271322. Epub 2016 Feb 24.

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies

López González I, Garcia-Esparcia P, Llorens F, Ferrer I.

Int J Mol Sci. 2016 Feb 4;17(2):206. doi: 10.3390/ijms17020206.

Validation of conversion between mini-mental state examination and montreal cognitive assessment

Lawton M, Kasten M, May MT, Mollenhauer B, Schaumburg M, Liepelt-Scarfone I, Maetzler W, Vollstedt EJ, Hu MT, Berg D, Ben-Shlomo Y.

Mov Disord. 2016 Apr;31(4):593-6. doi: 10.1002/mds.26498. Epub 2016 Feb 10.

Nonmotor features of Parkinson's disease subtypes

Marras C, Chaudhuri KR.

Mov Disord. 2016 Aug;31(8):1095-102. doi: 10.1002/mds.26510. Epub 2016 Feb 10.

Abnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease

Someko H, Hanajima R, Tsutsumi R, Tominaga N, Nomura Y, Hoshino K, Nishiyama K.

Mov Disord. 2016 Mar;31(3):422-3. doi: 10.1002/mds.26523. Epub 2016 Feb 10.

Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait

Heremans E, Nackaerts E, Vervoort G, Broeder S, Swinnen SP, Nieuwboer A.

PLoS One. 2016 Feb 10;11(2):e0148933. doi: 10.1371/journal.pone.0148933. eCollection 2016.

Once STN DBS, Always STN DBS?-Clinical, Ethical, and Financial Reflections on Deep Brain Stimulation for Parkinson's Disease

Hariz M.

Mov Disord Clin Pract. 2016 Feb 11;3(3):285-287. doi: 10.1002/mdc3.12292. eCollection 2016 May-Jun.

Alpha-synuclein: relating metals to structure, function and inhibition

McDowall JS, Brown DR.

Metallomics. 2016 Apr;8(4):385-97. doi: 10.1039/c6mt00026f. Epub 2016 Feb 11.

Our first decade of experience in deep brain stimulation of the brainstem: elucidating the mechanism of action of stimulation of the ventrolateral pontine tegmentum

Mazzone P, Vilela Filho O, Viselli F, Insola A, Sposato S, Vitale F, Scarnati E.

J Neural Transm (Vienna). 2016 Jul;123(7):751-767. doi: 10.1007/s00702-016-1518-5. Epub 2016 Feb 11.

Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease

Duda J, Pötschke C, Liss B.

J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):156-178. doi: 10.1111/jnc.13572. Epub 2016 Mar 23.

Age at onset and Parkinson disease phenotype

Pagano G, Ferrara N, Brooks DJ, Pavese N.

Neurology. 2016 Apr 12;86(15):1400-1407. doi: 10.1212/WNL.0000000000002461. Epub 2016 Feb 10.

Urinary LRRK2 phosphorylation: Penetrating the thicket of Parkinson disease?

Grünewald A, Klein C.

Neurology. 2016 Mar 15;86(11):984-5. doi: 10.1212/WNL.0000000000002438. Epub 2016 Feb 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias